Inventor · disambiguated record
Patrice Denefle
Also filed as: DENEFLE PATRICE
19 granted patents·16 pending applications·354 citations·filing 1994–2016
94Inventor score
Files withAVENTIS PHARMA SA13RHONE POULENC RORER SA4AVENTIS PHARM PROD INC2AVENTIS PHARMA INC2DENEFLE PATRICE2
Top patents by PatentIndex Score
35 records- 0190US5851521AViral vectors and their use for treating hyperproliferative disorders, in particular restenosisUNIV CASE WESTERN RESERVE·Filed 1996·Granted Dec 22, 1998·87 cites·36 claims
- 0284US6512161B1Transgenic rabbit that expresses a functional human lipoprotein (a)AVENTIS PHARMA INC·Filed 1999·Granted Jan 28, 2003·76 cites·22 claims
- 0382US5866551ARecombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemiasRHONE POULENC RORER SA·Filed 1994·Granted Feb 2, 1999·40 cites·11 claims
- 0477US5792902ADyslipoproteinaemia-sensitized transgenic rabbitRHONE POULENC RORER SA·Filed 1995·Granted Aug 11, 1998·36 cites·20 claims
- 0576US6033885AIntegrative recombinant adenoviruses, preparation thereof and therapeutical uses thereofRHONE POULENC RORER SA·Filed 1995·Granted Mar 7, 2000·38 cites·31 claims
- 0674US6814962B1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameAVENTIS PHARMA SA·Filed 2000·Granted Nov 9, 2004·3 cites·15 claims
- 0771US6258596B1Variants of apolipoprotein A-IAVENTIS PHARM PROD INC·Filed 1996·Granted Jul 10, 2001·46 cites·23 claims
- 0866US9540693B2Mutations of the parkin gene, compositions, methods and usesAVENTIS PHARMA SA·Filed 2014·Granted Jan 10, 2017·0 cites·18 claims
- 0963US2005163754A1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameUNIV BRITISH COLUMBIA·Filed 2004·Application pending·0 cites
- 1061US2009257981A1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameUNIV BRITISH COLUMBIA·Filed 2007·Application pending·0 cites
- 1159US6410011B1Gene therapy for restenosis using an adenoviral vectorAVENTIS PHARMA SA·Filed 1995·Granted Jun 25, 2002·15 cites·24 claims
- 1258US7972844B2Nuclear factor κB inducing factorAVENTIS PHARMA INC·Filed 2006·Granted Jul 5, 2011·0 cites·4 claims
- 1356US6893841B2Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereofAVENTIS PHARMA SA·Filed 2002·Granted May 17, 2005·2 cites·10 claims
- 1455US8642739B2Nuclear factor κB inducing factorDENEFLE PATRICE·Filed 2011·Granted Feb 4, 2014·0 cites·9 claims
- 1555US8623831B2Nuclear factor κB inducing factorDENEFLE PATRICE·Filed 2011·Granted Jan 7, 2014·0 cites·6 claims
- 1654USRE37933EViral vectors and their use for treating hyperproliferative disorders, in particular restenosisUNIV CASE WESTERN RESERVE·Filed 2000·Granted Dec 10, 2002·0 cites·50 claims
- 1754US2017183736A1Mutations of the parkin gene, compositions, methods and usesAVENTIS PHARMA SA·Filed 2016·Application pending·0 cites
- 1853US7041497B2Nuclear factor κB inducing factorAVENTIS PHARM PROD INC·Filed 2001·Granted May 9, 2006·0 cites·9 claims
- 1953US2013164262A1Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to SameBENOIT PATRICK·Filed 2012·Application pending·0 cites
- 2051US8835618B2Mutations of the parkin geneBRICE ALEXIS·Filed 2011·Granted Sep 16, 2014·0 cites·18 claims
- 2151USRE38556ERecombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemiasAVENTIS PHARMA SA·Filed 1994·Granted Jul 13, 2004·7 cites·17 claims
- 2251US2006063166A1Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids and uses thereofAVENTIS PHARMA SA·Filed 2004·Application pending·0 cites
- 2348US2002094324A1Gene therapy for restenosis using an adenoviral vectorAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 2446US2004185456A1Nucleic and proteinic acids corresponding to human gene ABC1AVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 2546US2005158784A1Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereofAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 2644US2003077605A1Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids, and uses thereofFiled 2002·Application pending·0 cites
- 2743US2013210898A1Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to sameAVENTIS PHARMA SA·Filed 2013·Application pending·0 cites
- 2840US7378274B2Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic usesAVENTIS PHARMA SA·Filed 2001·Granted May 27, 2008·0 cites·11 claims
- 2939US2003056234A1Polymorphic sequences of the human ABCA1 gene, their uses, and detection methods and kits thereforFiled 2001·Application pending·0 cites
- 3037US2003077591A1Nucleic acid for regulating the ABCA7 gene, molecules modulating its activity and therapeutic applicationsFiled 2001·Application pending·0 cites
- 3134US7998667B1Mutations of the parkin gene, compositions, methods and usesAVENTIS PHARMA SA·Filed 1999·Granted Aug 16, 2011·4 cites·33 claims
- 3234US2003044895A1Nucleic acids of the human ABCA5, ABCA6, ABCA9, AND ABCA10 Genes, vectors containing such nucleic acids, and uses thereofFiled 2001·Application pending·0 cites
- 3333US2003087246A1Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereofFiled 2002·Application pending·0 cites
- 3423US2002144302A1Novel constructs and vectors for the targeted and inducible expression of genesFiled 1997·Application pending·0 cites
- 3522US2001014319A1Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapyRHONE POULENC RORER SA·Filed 1996·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrice Denefle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →